Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ABSORICA LD | sparc | N-211913 RX | 2019-11-05 | 4 products, RLD, RS |
ABSORICA | Sun Pharmaceutical Industries | N-021951 RX | 2012-05-25 | 6 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
acne vulgaris | EFO_0003894 | D000152 | L70 |
leukemia | — | D007938 | C95 |
neuroblastoma | EFO_0000621 | D009447 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroblastoma | D009447 | EFO_0000621 | — | 13 | 26 | 11 | 1 | 4 | 52 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | 6 | 3 | 3 | 9 | 13 | 33 |
Covid-19 | D000086382 | — | U07.1 | 1 | 4 | 2 | 1 | 1 | 9 |
Dry eye syndromes | D015352 | — | H04.12 | — | — | — | 1 | — | 1 |
Proliferative vitreoretinopathy | D018630 | EFO_1001129 | — | — | — | — | 1 | — | 1 |
Seborrheic dermatitis | D012628 | HP_0001051 | L21 | — | — | — | 1 | — | 1 |
Second primary neoplasms | D016609 | — | — | — | — | — | 1 | — | 1 |
Acneiform eruptions | D017486 | EFO_1000662 | — | — | — | — | 1 | — | 1 |
Olfaction disorders | D000857 | HP_0000458 | R43.0 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ganglioneuroblastoma | D018305 | — | — | 1 | 2 | 2 | — | — | 5 |
Retinoblastoma | D012175 | — | — | 3 | — | 2 | — | — | 5 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | — | 3 | 1 | — | 1 | 5 |
Central nervous system neoplasms | D016543 | — | — | — | 1 | 2 | — | — | 3 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 1 | 1 | — | — | 3 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | 1 | 1 | — | — | 3 |
Myelodysplastic syndromes | D009190 | — | D46 | 2 | 1 | 1 | — | — | 3 |
Medulloblastoma | D008527 | — | — | 2 | — | 1 | — | — | 3 |
Eczema | D004485 | HP_0000964 | L30.9 | — | — | 2 | — | — | 2 |
Head and neck neoplasms | D006258 | — | — | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioblastoma | D005909 | EFO_0000515 | — | 2 | 3 | — | — | — | 4 |
Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 2 | 1 | — | — | — | 3 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | 1 | — | — | 2 | 3 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | — | 3 | — | — | — | 3 |
Leukemia | D007938 | — | C95 | 2 | 3 | — | — | — | 3 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | 2 | — | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | — | 2 | — | — | — | 2 |
Glioma | D005910 | EFO_0000520 | — | 1 | 1 | — | — | — | 2 |
Lamellar ichthyosis | D017490 | — | Q80 | — | 2 | — | — | — | 2 |
Hepatic insufficiency | D048550 | — | — | 1 | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 5 | — | — | — | — | 5 |
Neoplasms | D009369 | — | C80 | 3 | — | — | — | — | 3 |
Myeloid leukemia acute | D015470 | — | C92.0 | 2 | — | — | — | — | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | 1 | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | — | — | — | — | 2 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 2 | — | — | — | — | 2 |
Burkitt lymphoma | D002051 | — | C83.7 | 2 | — | — | — | — | 2 |
Lymphomatoid granulomatosis | D008230 | — | C83.8 | 2 | — | — | — | — | 2 |
Gliosarcoma | D018316 | — | — | 1 | — | — | — | — | 1 |
Astrocytoma | D001254 | EFO_0000271 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Papillomaviridae | D027383 | — | — | — | — | — | — | 1 | 1 |
Malformed nails | D009264 | — | Q84.5 | — | — | — | — | 1 | 1 |
Muscle strength | D053580 | — | — | — | — | — | — | 1 | 1 |
Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 1 | 1 |
Musculoskeletal diseases | D009140 | — | — | — | — | — | — | 1 | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 1 | 1 |
Contraception | D003267 | — | — | — | — | — | — | 1 | 1 |
Stevens-johnson syndrome | D013262 | EFO_0004276 | L51.1 | — | — | — | — | 1 | 1 |
Asthma | D001249 | EFO_0000270 | J45 | — | — | — | — | 1 | 1 |
Melanoma | D008545 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Isotretinoin |
INN | isotretinoin |
Description | Isotretinoin is a retinoic acid that is all-trans-retinoic acid in which the double bond which is alpha,beta- to the carboxy group is isomerised to Z configuration. A synthetic retinoid, it is used for the treatment of severe cases of acne and other skin diseases. It has a role as a keratolytic drug, an antineoplastic agent and a teratogenic agent. It is a conjugate acid of a 13-cis-retinoate. |
Classification | Small molecule |
Drug class | retinol derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1 |
PDB | — |
CAS-ID | 4759-48-2 |
RxCUI | — |
ChEMBL ID | CHEMBL547 |
ChEBI ID | 6067 |
PubChem CID | 5282379 |
DrugBank | DB00982 |
UNII ID | EH28UP18IF (ChemIDplus, GSRS) |